002630.KO ORIENTBIO Inc.

Healthcare Life Sciences Tools & Services Korea Stock Exchange
1,193 KRW
Close of Nov 4, 2026
1,151 3,264
Market cap
KRW 35.4B
P/E
-
P/B
0.48x
ROE
26.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 002630.KO undervalued?

Graham number

The Graham number of ORIENTBIO Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ORIENTBIO Inc. fundamental analysis

No fundamental analysis for ORIENTBIO Inc. yet.

ORIENTBIO Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ORIENTBIO Inc.

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs …

Full company profile